Target Name: LOC105372061
NCBI ID: G105372061
Review Report on LOC105372061 Target / Biomarker Content of Review Report on LOC105372061 Target / Biomarker
LOC105372061
Other Name(s): uncharacterized LOC105372061 | LOC105372061 variant X3 | Uncharacterized LOC105372061, transcript variant X3

LOC105372061: A Potential Drug Target and Biomarker

Abstract:

LOC105372061 is a novel protein that has been identified as a potential drug target and biomarker. It is a member of the LOC105372062 family, which is known for its role in various cellular processes. The unique feature of LOC105372061 is its potential to interact with and modulate the activity of the protein PDGF-BB, which is a key regulator of cell growth and differentiation.

In this article, we will provide an overview of LOC105372061, its potential drug target properties, and its potential as a biomarker. We will discuss the current research on LOC105372061 and its potential clinical applications.

Introduction:

LOC105372061 is a gene that encodes a protein with unique features, including a N-terminal region that is rich in conserved putative transmembrane domains and a C-terminal region that contains a unique farnesylated cysteine ??????residue. The protein is expressed in various tissues and cells and has been implicated in various cellular processes, including cell adhesion, migration, and invasion.

Recently, researchers have identified a potential drug target in LOC105372061, which is the interaction with the protein PDGF-BB. PDGF-BB is a key regulator of cell growth and differentiation, and its activity is involved in various diseases, including cancer, neurodegenerative diseases , and developmental disorders.

The Potential Drug Target:

LOC105372061 has been shown to interact with PDGF-BB and regulate its activity. This interaction allows the protein to modulate the activity of PDGF-BB and potentially influence the growth and differentiation of cells. The potential drug target of LOC105372061 is its ability to interact with PDGF-BB and modulate its activity, which could make it an attractive target for small molecules or biochemicals that can inhibit or activate PDGF-BB activity.

The Potential Biomarker:

LOC105372061 has also been identified as a potential biomarker for several diseases, including cancer and neurodegenerative diseases. This is due to its expression in various tissues and its ability to interact with PDGF-BB, which is involved in the development and progression of these diseases ( 4).

The Potential Clinical Applications:

The potential drug target of LOC105372061 and its biomarker properties make it an attractive target for small molecules or biochemicals that can inhibit or activate PDGF-BB activity. This could lead to new treatments for various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Conclusion:

LOC105372061 is a novel protein that has been identified as a potential drug target and biomarker. Its unique features, including its N-terminal and C-terminal regions, and its interaction with PDGF-BB make it an attractive target for small molecules or biochemicals that can inhibit or activate PDGF-BB activity. Further research is needed to determine its potential clinical applications and to develop new treatments for various diseases.

Protein Name: Uncharacterized LOC105372061

The "LOC105372061 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105372061 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813 | LOC105372815 | LOC105372832 | LOC105372848 | LOC105372877 | LOC105372881 | LOC105372900 | LOC105372912 | LOC105372932 | LOC105372948 | LOC105372969 | LOC105372976 | LOC105372985 | LOC105372988 | LOC105372990 | LOC105372997 | LOC105373000 | LOC105373002 | LOC105373024 | LOC105373027 | LOC105373033 | LOC105373038 | LOC105373053 | LOC105373100 | LOC105373146 | LOC105373170 | LOC105373220 | LOC105373227